Like other immunotherapies, PD-L1 inhibitors can cause side effects, primarily due to increased immune activity. Common side effects include fatigue, rash, diarrhea, and thyroid gland inflammation. More severe side effects can include pneumonitis, hepatitis, colitis, and endocrinopathies, necessitating careful monitoring during treatment.
